Showing results (1-10 of 113) with videos related to
Sort By:
Pageof 12
Expert Opinion on Pharmacotherapy|November 27, 2020
An update on the efficacy and safety of novel anticoagulants for cancer associated thrombosisBenilde CosmiCurrent Opinion in Molecular Therapeutics|May 30, 2009
ARC-1779, a PEGylated aptamer antagonist of von Willebrand factor for potential use as an anticoagulant or antithrombotic agentBenilde CosmiExpert Review of Hematology|September 15, 2015
Current management of heparin-induced thrombocytopeniaBenilde CosmiExpert Opinion on Pharmacotherapy|September 30, 2016
An update on the pharmaceutical management of thrombosisBenilde CosmiExpert Review of Cardiovascular Therapy|October 15, 2016
Management of idiopathic venous thromboembolismBenilde CosmiHematology Reports|March 22, 2021
Heparin-induced thrombocytopenia and COVID-19Michelangelo Sartori, Benilde CosmiCurrent Opinion in Hematology|July 17, 2004
Predicting the risk of recurrence of venous thromboembolismGualtiero Palareti, Benilde CosmiJournal of Thrombosis and Thrombolysis|January 27, 2018
Andexanet alfa to reverse the anticoagulant activity of factor Xa inhibitors: a review of design, development and potential place in therapyMichelangelo Sartori, Benilde CosmiSeminars in Vascular Medicine|June 17, 2004
Oral anticoagulant therapy in venous thromboembolismBenilde Cosmi, Gualtiero PalaretiThrombosis and Haemostasis|August 5, 2009
Bleeding with anticoagulation therapy - who is at risk, and how best to identify such patientsGualtiero Palareti, Benilde CosmiPageof 12